| Authors: |
Johannes CB; RTI Health Solutions, Waltham, MA, USA., Ziemiecki R; RTI Health Solutions, Research Triangle Park, NC, USA., Pladevall-Vila M; RTI Health Solutions, Barcelona, Spain.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA., Ebert N; Charité-Universitätsmedizin Berlin, Berlin, Germany., Kovesdy CP; Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA., Thomsen RW; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Baak BN; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., García-Sempere A; Valencia Health System Integrated Database, Health Services Research Unit, Valencia, Spain., Kanegae H; Genki Plaza Medical Centre for Health Care, Tokyo, Japan., Coleman CI; University of Connecticut School of Pharmacy, Storrs, CT, USA.; Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA., Walsh M; Division of Nephrology, Department of Medicine, McMaster University, Hamilton, ON, Canada., Andersen IT; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Rodríguez Bernal C; Valencia Health System Integrated Database, Health Services Research Unit, Valencia, Spain., Robles Cabaniñas C; Valencia Health System Integrated Database, Health Services Research Unit, Valencia, Spain., Christiansen CF; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Farjat AE; Bayer AG, Berlin, Germany., Gay A; Bayer AG, Berlin, Germany., Gee P; National Kidney Foundation Advocacy, Richmond, VA, USA., Herings RMC; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Hurtado I; Valencia Health System Integrated Database, Health Services Research Unit, Valencia, Spain., Kashihara N; Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan., Kristensen FPB; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Liu F; Bayer AG, Berlin, Germany., Okami S; Bayer AG, Berlin, Germany., Overbeek JA; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Penning-van Beest FJA; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Yamashita S; Bayer AG, Berlin, Germany., Yano Y; NCD Epidemiology Research Center, Shiga University of Medical Science, Shiga, Japan.; Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan., Layton JB; RTI Health Solutions, Research Triangle Park, NC, USA., Vizcaya D; Bayer AG, Berlin, Germany., Oberprieler NG; Bayer AG, Berlin, Germany. niki.oberprieler@bayer.com.; Bayer AS, Oslo, Norway. niki.oberprieler@bayer.com. |
